Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $6.69B | $6.35B | +5.26% |
Cost of Revenue | $1.55B | $1.4B | +10.78% |
Operating Income | $-4.32B | $1.71B | -353.49% |
Net Income | $-4.17B | $1.01B | -512.87% |
EPS (Basic) | $-3.34 | $0.81 | -512.35% |
EPS (Diluted) | $-3.34 | $0.80 | -517.50% |
SG&A Expense | $1.38B | $1.32B | +4.25% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $56.29B | $61.88B | -9.02% |
Current Assets | $14.04B | $13.46B | +4.35% |
Current Liabilities | $13.02B | $10.53B | +23.62% |
Stockholders' Equity | $17.54B | $21B | -16.47% |
Long-Term Debt | $25.19B | $25.24B | -0.18% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $2.22B | $1.74B | +27.24% |
Investing Cash Flow | $-2.21B | $-826M | -167.19% |
Financing Cash Flow | $-1.36B | $-1.41B | +3.20% |
Dividends Paid | $990M | $969M | +2.17% |
Share Buybacks | $400M | $400M | 0.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -64.6% | 26.8% | -91.48% |
Net Margin | -62.4% | — | — |
ROE | -23.8% | — | — |
ROA | -7.4% | — | — |
Current Ratio | $1.079 | — | — |
Other companies in Biotechnology